Comparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial Fibrillation
Clinical trial NCT02666157 · UNKNOWN
Trial details
- NCT number
- NCT02666157
- Sponsor
- National Cheng-Kung University Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2018-12-01
- Enrollment
- 3672
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.